REPAY Announces Chief Financial Officer Transition
ATLANTA–(BUSINESS WIRE)–Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY” or the “Company”), a leading provider of integrated... Read more.
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA–(BUSINESS WIRE)–Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics’ Board... Read more.
Spire Global Completes Sale of Maritime Business; Debt Eliminated
VIENNA, Va.–(BUSINESS WIRE)–$SPIR—Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of... Read more.
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™... Read more.
Generational Group Advises Denmark Sausage Co. in its Sale to Premium Brands Holdings Corporation
DALLAS–(BUSINESS WIRE)–Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the... Read more.
PENN Entertainment Announces Board Refreshment
WYOMISSING, Pa.–(BUSINESS WIRE)–PENN Entertainment, Inc. (“PENN” or the “Company”) (Nasdaq: PENN) today announced that it... Read more.
Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation... Read more.
BancPlus Corporation Announces Quarterly Cash Dividend
RIDGELAND, Miss.–(BUSINESS WIRE)–BancPlus Corporation, the holding company for BankPlus, today announced that on April 24, 2025, its Board of Directors... Read more.
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China
Interim Analysis of HARMONi-2 Shows an Overall Survival Hazard Ratio of 0.777 Favoring Ivonescimab at 39% Data Maturity, Implying a Potential Numerical 22% Reduction... Read more.
AM Best Affirms Credit Ratings of Principal Financial Group, Inc. and Its Subsidiaries
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings... Read more.